請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/76155完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.author | 林翰佐 | zh_TW |
| dc.date.accessioned | 2021-07-01T08:18:36Z | - |
| dc.date.available | 2021-07-01T08:18:36Z | - |
| dc.date.issued | 1995 | |
| dc.identifier.citation | 1. Vogelstein, B., and Kinzler, K.W. (1993). The multistep nature of cancer. Trend. in Genetics, 9(4):138-141. 2. Bishop, J.M. (1991). Molecular themes in oncogenesis. Cell, 64:235-248. 3. Hunter, T., (1991). Cooperation between oncogenes. Cell, 64:249-270. 4. Cantley, L.C., Auger, K.R., Carpenter, B., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S. (1991). Oncogenes and signal transduction. Cell, 64:281-302. 5. Lewin, B. (1991). Oncogenic conversion by regulatory changes in transcription factors. Cell, 64:327-336. 6. Liotta, L.A., Steeg, P.S., and Stetler-stevenson, W.G. (1991). Cancer metastasis and angiogenesis: a inbalence of positive and negative regulation. Cell, 64: 327-336. 7. Henderson, B.E., Ross, R.K., and Pike, M.C. (1991). Toward the primary prevention of cancer. Science, 254:1131-1138. 8. Solomon, E., Borrow, J., and Goddaro, A.D. (1991). Chromosome aberations and cancer. Science, 254:1153-1160. 9. Hartwall, L.H. and Kastan, M.B. (1994). Cell cycle contral and cancer. Science, 266:1821-1828. 10. Weinberg., R.A. (1991) Tumor superssor gene. Science, 254:1138-1146. 11. Lee, L.-N., Shew, J.-Y., Sheu, J.-C., Lee, Y.-C., Lee, W.-C., Fang, M.-T., Chang, H.-F., Yu, C.-J., Yang, P.-C. and Luh, K.-T. (1994). Exon 8 mutation of p53 gene associatied with nodal metastasis in non-small-cell lung cancer. Am. J. Respir. Crit. Care. Med., 150:1667-1671. 12. Darkins, H.J.S., Robbins, P.D., Smith, K.L., Sarna, M. Harvery, J.M., Sterrett, G.F. and Papadimitrion, J.M. (1993). What's new in breat cancer molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease. Path. Res. Pract., 189:1233-1252. 13. Piatak, M., Luk, K.C., Williams, B., and Lifson, J.D. (1993). Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques 14(1), 71-79. 14. Francesco, S.C., Zenilman, M.E. and Shuldiner, A.R. (1993). A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic acid research, 21(4), 1047. 15. 行政院衛生署，中華民國八十年衛生統計－二，生命統計。臺北市，行政 院衛生署，中華民國八十一年。 16. Chen, C.-J., Wu, H.-Y., Chuang, Y.-C., Chang, A.-S., Luh, K.-T., Chao, H.-H., Chen, K.-Y., Chen, S.-G., Lai, G.-M., Huang, H.-H., and Lee, H.-H. (1990). Epidermiologic characteristics and multiple risk factors of lung cancer in Taiwan. Anticancer research, 10:971-976. 17. Luh, K.-T., Kuo, S.-H., Lin, C.-C., Yang S.-P., and Chen, K.P. (1974). Primary lung cancer in Taiwan: part 1. Chronological observation of epidermiologic characteristical characteristics with etiological consideration. J. Formosan Med. Assoc., 73:129-146. 18. Palazzo, I.E.G., Adams, G.P., Sundareshan, P., Wang, A.J., Testua, J.R., Bigner, D.D. and Weiner, L.M. (1993) Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res., 53:3217-3220. 19. Chiba, I., Takahashi, T., Nau, M.M., Amico, D.D., Curiel, D.J., Mitsudomi, T., Buchhagen, D.C., Carbone, D., Piaritadesi, S., Koga, H., Reissman, P.T., Slamon, D.J., Holmes, E.C., and Minna, J.D. (1993). Mutation in the p53 gene are frequent in primary, restected non-small cell lung cancer. Oncogene, 8:1913-1919. 20. Yang, S.-P., Luh, K.-T., Kuo, S.-H., Lin, C.-C. (1984). Chronological observation of epidermiologic characteristics in Taiwan with etiological considereration: a 30-years consecutive study. Jpn. J. Clin. Oncol., 14:17-19. 21. Little, C.D., Nau, N.N., Carney, D.N., Gazard, A.F., and Minna, J.D. (1983). Amplification and expression of the c-mye oncogene in human lung cancer cell lines. Nature, 306:194-196. 22. Takahashi, T., Obata, Y., Sekido, Y., Hida, T. Ueda, R., Watanabe, H., Ariyoshi, Y., Sugiura, T., and Takahashi, T. (1989). Expression and amplification of myc gene family in small cell lung cancer and its relation to biological charactistics. Cancer Res., 49:2683-2688. 23. Noguchi, M., Murakami, M., Bennett, W., Lupu, R., Hui, F., Harris, C.C., and Gerwin, B.I. (1993). Biological consequences of overexperession of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells. Cancer Res., 53:2035-2043. 24. Weiner, D.B., Nordberg, J., Robinson, R., Norwell, P.C., Gazdar, A., Green, MM.I., William, W.V., Cohan, J.A., and Kern J.A. (1990). experssion of the neu gene-encoded protein in human non-small cell carcinoma of the lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7:171-180. 25. Mitsudomi, T., Steinberg, S.M., Nau, M.M., Carbone, D., Amico, D.D., Bodner, S., Oie, H.K., Linnoila, H.R., Mulshine, J.C., Minna, J.D. and Gazdar, A.F. (1992). p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7:171-180. 26. Suzuki, Y., Orita, M., Shiraishi, M., Hayashi, K., and Seikiya, T. (1990). Detection of ras gene mutation in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction. Oncogene, 5:1037-1043. 27. Suzuki, H., Takahashi, T., Suyama, M., Ariyosh, Y., Takahashi, T., and Ueda, R. (1992). p53 mutations in non-small cell lung cancer. Cancer Res., 52:734-736. 28. Amico, D.D., Carbone, D., Mitsudomi, T., Nau, M., Fedorko, J., Russell, E., Johnson, B., Buchhagen, D., Bodner, S., Phelps, R., Gazdar, A. and Minna, J.D. (1992). High frequency of somatically acquired p53 mutation in small cell lung cancer cell lines and tumor. Oncogene, 7:339-346. 29. Harbour, J.W., Lai, S.L., Gazdar, A.F., Minna, J.D., and Kare, F.J. (1989). Abnormalities in structure and expression in primary non-small cell lung carcenoma. Cancer Res., 51:2735-2739. 30. Xu, H.J., Hu, S.X., Cagle, P.T., Moore, G.F., and Benedict, W.F. (1991). Abscence of retinoblastoma protein expression in primary non-small cell lung carcimona. Cancer Res., 51:2735-2739. 31. Reissman, P.T., Koga, H., Takahashi, R., Figlin, R.A., Holmes, E.C., Piantadsi, S., Cordon-Cardo, C., Slamon, D.J., and the lung cancer study gr. (1993). Inactivation of the retinoblastoma susceptibility gene in non-small cell lung cancer. Oncogene, 8:1913-1919. 32. Hensel, C.H., Hsieh, C.L., Gazdar, B.E., Johnson, B.E., Sakaguchi, A Y., Naylor, S.L., Lee, W.H. and Lee, E.R. (1990). Altered structure and experssion of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res., 50:3067-3072. 33. Mori, N., Yok, J., Akiyoma, T., Samechima, Y., Okamoto, A., Mizoguchi, H., Toyoshima, K., Sugimura, T., and Terda, M. (1990). Variable mutations of rb gene in small-cell lung carcinoma cells carrying multiple genetic alterations. Oncogene, 8:2175-2182. 34. Okawa, K., Shisek, M., Takahashi, R., Yoshida, Y., Terada, MM., and Yokota, J. (1993). Reconstitution or rb gene suppersses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations: Oncogene, 8:2175-2181. 35. Mori, N., Yokota, J., Oshimura, M., Carenee, W.K., Mizogueshi, H., Noguchi, M., Shimosato, Y., Sugimura, T., and Terada, M. (1989). Condordant delitions of chromosome 3p and loss of heterozygosity for chromosome 13 and 17 in small cell lung carcinoma. Cancer Res., 49:5130-5135. 36. Sundaresan, V., Ganly, P., Russ, R., Sinha, G., Bleehen, N.M., and Rabbitts, P. (1993) p53 and chromosome 3 abnormalitites, characteristic of malignant lung cancer tumor, are detective in preinvasive leisions of the bronchus. Oncogene, 7: 1989-1997. 37. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. (1986). Similarity of protein encoded by the human e-erbB-2 gene to epidermal growth factor. Nature, 319:230-234. 38. Bargmann, C.I., Hung, M.-C., and Weinberg, R.A., (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature, 319:226-230. 39. Schechter, A.L., Hung, M.-C., Vaidyanathan, L., Weinberg, R.A., Yang-Feng, T.L., Francke, U., Ullrich, A., and Coussens, L. (1985). The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF-recepter. Science, 229:976-978. 40. Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., and Yamamoto, T. (1986). the product of human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science, 232:1644-1646. 41. Coussens, L., Yang-Feng, T.L., Liao, Y.-C., Chen, E., Gray, A., Mcgrath, J., Seeburg, P.H., Libermann, T.A., Schlessinger, J., Francke, U., Levinson, A., and Ullrich, A. (1985). Tyrosine kinas receptor with extensive homology of EGF receptor shares chromosomal location with neu oncogene. Science, 230:1132-1139. 42. Stern, D.F., Heffernam, P.A., and Weinberg, R.A. (1986). p185, a product of the neu protooncogene, is a receptor like protein associated with tyrosine kinase activity. Mol. Cell. Biol. 6:1729-1740. 43. Yarden, Y., and Ullrich, A. (1900). Growth factor receptor tyrosine kinases. Annu. Rev. Biochem., 57:443-478. 44. Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D., and Yarden, Y. (1993). Cell type specific interaction of neu differentiation factor (NDF/heregulin) with /HER-2 suggect complex ligand-receptor relationships. EMBO J., 12:961-971. 45. Carraway, K.L., Sliwkowski, M.X., Akita, R., Platko, J.V., Guy, P.M., Nuijens, A., Diamonti, A.J., Vandlen, R.L., Cantley, L.C., and Cerione, R.A. (1994). The erbB3 gene product is a receptor for herigulin. J. Biol. Chem., 269:14303-14306. 46. Sliwkowski, M.X., Schaefer, G., Akita, R.W., Lofgren, J.A., Fitzpatrick, V.D., Nuijens, A., Fendly, B.M., Cerione, R.A., Vandlen, R.L., and Carraway, K.L., III. (1994). Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem., 269:14661-14665. 47. Plowman, G.D., Green, J.M., Culouscou, J.-M., Carlton, G.W., Rothwell, V.M., and Buckley, S. (1993). Heregulin induced tyrosine phosphorylation of HER4/p180 erbB4. Nature, 366:437-475. 48. Carraway, K.L., III, and Cantley, L.C. (1994). A neu acquaintance for erbB3 and erbB4: a role for receptor hetrodimerization in growth signaling. Cell, 78:5-8. 49. Yu, D., Wang, S.-S., Dulski, K.M., Tsai, C.-M., Nicolson, G.L., and Hung, M.-C. (1994). C-erbB-2/neu overexpression enhances metastastic potential of human lung cancer cell by induction of metastasis-associated propeties. Cancer Res. 54:3260-3266. 50. Kern, J.A., Schwartz, D.A., Nordberg, J.E., Weiner, D.B., Greene, M.I., Torney, L., and Robinson, R.A. (1990). p185 neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res., 50:5184-5191. 51. Plowman, G.D., Green, J.M., Culouscou, J.-M., Carlton, G.W., Rothwell, V.M., and Buckley, S. (1993). Heregulin induced tyrosine phosphorylation of HER4/p180 erbB4. Nature, 366:437-475. 52.Guillemot, F., Billault, A., and Auffery, C. (1989) Physical linkage of a guanine nucleotide-binding protein-related gene to the chicken major histocompatibility complex. Proc. Natl Acad. Sci. USA, 86:4594-4598. 53.Guillemot, F., Billault, A., and Auffery, C. (1989) Physical linkage of a guanine nucleotide-binding protein-related gene to the chicken major histocompatibility complex. Proc. Natl Acad. Sci. USA, 86:4594-4598. 54. Weiner, D.B., Norberg, J., Norwell, P.C., et al. (1990). Expression of the neu gene encoded protein protein (pl85neu) in human non-small cell lung carcinomas of the lung. Cancer Res., 50:421-425. 55. Leone, A., McBride, O.W., Weston, A., Wang, M.G., Anglard, P., Cropp, C.S., Goepel, J.R., Lidereau, R., Callahan, R., Linehan, W.M., Rees, R.C., Harris, C.C., Liotta, L.A., Steeg, P.S. (1991). Somatic allelic delition of nm-23-H1 in human cancer. Cancer Res., 51:2409-2493. 56. Steeg, P.S., Rosa, A.D.L., Flatow, U., MacDonald, N.J., Benedict, M., and Leono, A. (1993). Nm23 and breast cancer metastasis. Breast Cancer Research and Treatment, 25:175-187. 57. Yang, P.-C., Luh, K.-T., Wu, L.R., and Wu, C.-W. (1992). Characterization of the mucin differentiation in human lung adenocarcinoma cell lines. Am. J. Respir. Cell Mol. Biol., 7:161-171. 58. Ogata, S., Uehara, H., and Itzkowitz, S.H. (1992). Mucin gene expression in colonic tissues and cell lines. Cancer Res., 52:5971-5978. 59. Park, J.W., Hong, K., Carter, P., Asgari, H., Guo, L.Y., Keller, G.A., Wirth, C., Shalaby, R., Kotts. C., Wood, W.I., Papahadjopoulos, D., and Benz, C.C. (1995). Development of anti-p185Her2 immumoliposomes for cancer therapy. Proc. Natl. Acad. Sci. USA. acceppted. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/76155 | - |
| dc.description.abstract | 目前已有多種分子生物技術用來檢測癌症檢體中致癌基因與抑癌基因的變化情形，並由大量的資料中得到一些有趣的關聯。其中包括neu基因的倍增／過量表現（DNA amplification/over expression） 與癌症轉移（metastasis）具有明顯的關聯性，但也有對此研究結果持否定的看法。這是因為所使用的技術無法精確的定量所致，需要以更精確的方法來釐清這個問題。 競爭式定量聚合?連鎖反應法是一種測量RNA中特定基因表現量的方法。放入一已知量、與目標基因相似的內基準RNA與材料total RNA一起參與反應，競爭所有的資源，然後由反應後兩者cDNA量的比值來計算total RNA中目標基因RNA的量。與以往的方法相較，此法具有total RNA使用量少，精確等優點，使其更適合於檢體上的研究。 我參考自Piatak等人的文獻，在實驗室中建立競爭式定量聚合?連鎖反應法，並嘗試改良，以便更減少材料的使用量、並提高其準確性。所做的改良包括，將目標基因與控制組（GB-like）的內基準RNA與材料total RNA的逆轉錄反應合併進行，以及以85℃熱處理逆轉錄產物等等。經以細胞株total RNA為材料，反覆的測試，證明此法具有良好的穩定性，誤差均於20％以下。與條狀點墨雜交法相較，此法亦有較好的靈敏度。我並以此法檢測台灣地區非小細胞肺癌檢體中neu基因的表現量。在24個檢體中有4個檢體具有7?4倍不等的過量表現，惟與臨床上癌症的轉移並無明顯的關聯性。另外，與先前實驗室中檢測p53基因突變的資料相較，發現neu基因的過量表現與p53基因的突變並不會同時發生，可能是兩者均為癌化現象的重要因數，其一突變就會使致癌機率大增所致。由於收集的檢體量少，所得的結果僅供參考，需要往後的實驗證明。 | zh_TW |
| dc.description.abstract | Quantitative competitive polymerase chain reaction (QC-PCR) is an advanced method to quantitate the amount of specific RNA in cell. The major principle is that the known copy number of a synthetic truncated internal standard is introduced with the sample into the reverse transcription reaction mixture and PCR reaction mixture. Because of it's accuracy and small amount of RNA needed, QC-PCR is not only suitable for RNA quantitation from culture cells as well as from clinical specimens. According to previous studies of human lung and breast cancers, several laboratories have reported a significant association between neu gene DNA amplification/over-expression and tumor metastasis, However, this point is still debatable. The main issue is that method used for RNA was less accuracy such as immunohistochemistry (IHC) or DNA/RNA blot hybridization. In order to clearity this puzzle, a more sensitive and accurate technique is desired necessary. Therefore, a modified QC-PCR was set-up in our laboratory according to the protocol from Piatak. After modification, the stability of this method was increased dramatically. The sensitivity was examined by comparison with slot blot hybridization. Almost one order difference between QC-PCR and slot blot hybridization were observed. This method was then applied to analyze the neu status of non-small-cell lung cancers in Taiwan. Four of 24 cases examed have harbored the neu over-expression from four to seven times. However, due to the small sample size, the association between neu over-expression and tumor metastasis was not significant. The other interesting finding was that the p53 mutation and neu over-expression in tumor specimens examined were exclusively existed. The report here was just a preliminary data, further investigation will be necessary to elucidate the association between neu and metastasis as well as the biological role of p53 mutation/neu over-expression in neoplastic malignance. | en |
| dc.description.provenance | Made available in DSpace on 2021-07-01T08:18:36Z (GMT). No. of bitstreams: 0 Previous issue date: 1995 | en |
| dc.description.tableofcontents | 中文摘要……………………………………I 英文摘要……………………………………II 致謝……………………………………III 目次……………………………………IV 圖次……………………………………VII 第一章：緒論 1-1 競爭式定量聚合?連鎖反應法……………………………………1 1-2 肺癌簡介……………………………………3 1-3 Neu基因的介紹……………………………………5 1-4 目的……………………………………6 第二章：材料與方法 2-1 材料 a）檢體（speciemen）……………………………………7 b）細胞株……………………………………7 c）載體……………………………………7 d）引子（primers）……………………………………8 2-2 方法： 2-2-1 total RNA的製備 A）檢體的均質與氯化銫密度梯度分離法……………………………………9 B）Total RNA的製備……………………………………9 C）自細胞株中抽取total RNA……………………………………10 2-2-2 基本實驗技術 A）1％洋菜膠電泳的分析與製備。……………………………………10 B）自洋菜電泳膠片中純化DNA片段……………………………………11 C）6％非變性聚丙烯醯銨膠電泳……………………………………12 D）自非變性聚丙烯醯銨膠中純化DNA片段……………………………………12 2-2-3 競爭式定量聚合?連鎖反應法 A）內基準RNA的製備 a）內基準DNA片段的合成……………………………………13 b）載體的構築，篩選與製備……………………………………14 1．連接反應……………………………………14 2．勝任細胞的製備……………………………………14 3．勝任細胞有效率的測試……………………………………15 4．轉型反應……………………………………15 5．質體DNA的少量製備……………………………………16 6．質體DNA的大量製備……………………………………17 c）胞外轉錄反應……………………………………18 C）競爭式定量聚合?連鎖反應……………………………………19 a）逆轉錄反應……………………………………19 b）聚合?連鎖反應 1．neu基因的PCR反應……………………………………19 2．Gβ-like基因的PCR反應……………………………………20 c）電泳分析與拍照……………………………………20 d）光密度計的測量與數據的計算：……………………………………20 2-2-4 條狀點墨雜交法 A）探針的製備與純化……………………………………21 B）RNA條狀點墨雜交法 a）RNA的吸附……………………………………22 b）雜交反應……………………………………22 c）去探針反應……………………………………23 第三章 結果 3-1．競爭式定量聚合?連鎖反應法的建立 A）內基準RNA的製備……………………………………24 B）以細胞株total RNA為材料測試競爭式定量聚合?連鎖反應法……………………………………25 C）競爭式定量聚合?連鎖反應法與條狀點墨雜交法靈敏度的比較……………………………………26 D）競爭式定量聚合?連鎖反應法盲點的修正……………………………………26 3-2．以競爭式定量聚合?連鎖反應法來檢測台灣非小型細胞肺癌檢體中neu基因的表現量……………………………………27 第四章：討論： 4-1 競爭式定量聚合?連鎖反應的穩定性……………………………………30 4-2 競爭式定量聚合?連鎖反應與條狀點墨雜交法靈敏度之比較……………………………………31 4-3 以QC-PCR檢測台灣地區非小細胞肺癌中neu基因之表現……………………………………32 4-4 對於QC-PCR未來的應用……………………………………33 附圖：……………………………………35 附表：……………………………………43 參考文獻：……………………………………53 | |
| dc.language.iso | zh-TW | |
| dc.title | 競爭式定量聚合?連鎖反應法之建立與應用：台灣地區非小細胞肺癌檢體中，neu 基因表現量之研究 | zh_TW |
| dc.title | Establishment and Application of Quantitative Competitive Polymerase chain reaction: Quantitation of neu Gene Expression of Non-Small Cell Lung Carcinomas in Taiwan | en |
| dc.date.schoolyear | 83-2 | |
| dc.description.degree | 碩士 | |
| dc.relation.page | 69 | |
| dc.rights.note | 未授權 | |
| dc.contributor.author-dept | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 動物學研究所 | zh_TW |
| 顯示於系所單位： | 動物學研究所 | |
文件中的檔案：
沒有與此文件相關的檔案。
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。